EUVIMEDEUVIMED entdecken
Crossref

Soluble-Antigen-Based PET/MR for the Specific Detection of BCMA CAR+ T-Cell Lymphoma

Wenyao Zhou, Yuqi Meng, Yuxin Yan, Lijun Tang, Junjie Yan iD, Donghui Pan, Chongyang Chen, Yuping Xu, Lizhen Wang, Xinyu Wang iD, Min Yang iD

Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3675-3687

DOI: 10.1021/acs.molpharmaceut.6c00097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 28.05.2026. Verfasst von Wenyao Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, P. R. China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, B-Cell Maturation Antigen, Lymphoma, T-Cell, Receptors, Chimeric Antigen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Health and Wellness Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyB-Cell Maturation AntigenLymphoma, T-CellReceptors, Chimeric AntigenAnimalsHumansMiceGallium RadioisotopesImmunotherapy, AdoptiveCell Line, TumorHeterocyclic CompoundsFemaleMagnetic Resonance ImagingSingle-Chain AntibodiesHeterocyclic Compounds, 1-RingRadiopharmaceuticals

Stichwörter der Autor:innen

BCMACAR T-cell therapyPET/MRimagingsecondary T-cell malignancies

Substanzen

B-Cell Maturation AntigenReceptors, Chimeric AntigenGallium RadioisotopesHeterocyclic CompoundsSingle-Chain Antibodies1,4,7-triazacyclononane-N,N',N''-triacetic acidHeterocyclic Compounds, 1-RingRadiopharmaceuticalsGallium-68TNFRSF17 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, P. R. China.
  • National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, P. R. China.
  • Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, P. R. China.

ORCID-Profile: Junjie Yan, Xinyu Wang, Min Yang

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Health and Wellness Commission

Zitieren

APA

Zhou, W., Meng, Y., Yan, Y., Tang, L., Yan, J., Pan, D., Chen, C., Xu, Y., Wang, L., Wang, X., & Yang, M. (2026). Soluble-Antigen-Based PET/MR for the Specific Detection of BCMA CAR+ T-Cell Lymphoma. Molecular Pharmaceutics, 23(7), 3675-3687. https://doi.org/10.1021/acs.molpharmaceut.6c00097

Vancouver

Zhou W, Meng Y, Yan Y, Tang L, Yan J, Pan D, et al. Soluble-Antigen-Based PET/MR for the Specific Detection of BCMA CAR+ T-Cell Lymphoma. Molecular Pharmaceutics. 2026;23(7):3675-3687. doi:10.1021/acs.molpharmaceut.6c00097

BibTeX
@article{Zhou2026,
  author = {Zhou, Wenyao and Meng, Yuqi and Yan, Yuxin and Tang, Lijun and Yan, Junjie and Pan, Donghui and Chen, Chongyang and Xu, Yuping and Wang, Lizhen and Wang, Xinyu and Yang, Min},
  title = {Soluble-Antigen-Based PET/MR for the Specific Detection of BCMA CAR+ T-Cell Lymphoma},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {3675--3687},
  doi = {10.1021/acs.molpharmaceut.6c00097}
}
Kostenlos starten →